|
BaracludeDrug - Baraclude The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Entecavir
Strength -
0.5MG
Applicant -
BRISTOL MYERS SQUIBB
New Drug Application (NDA) Number -
021797
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Mar 29, 2005
Reference Listed Drug (RLD) -
No
Type -
RX
Applicant Full Name -
Bristol Myers Squibb
Baraclude
Lovenox (preservative Free) 60mg/0.6ml (100mg/ml) Injectable; Subcutaneous
Lovenox (preservative Free) 80mg/0.8ml (100mg/ml) Injectable; Subcutaneous Lovenox (preservative Free) 90mg/0.6ml (150mg/ml) **federal Register Determination That Product Was Not Discontinued Or Withdrawn For Safety Or Efficacy Reasons** Injectable; Subcutaneous Comtan 200mg Tablet; Oral Baraclude 0.05mg/ml Solution; Oral Baraclude 0.5mg Tablet; Oral Lovenox (preservative Free) 120mg/0.8ml (150mg/ml) Injectable; Subcutaneous Lovenox (preservative Free) 150mg/ml (150mg/ml) Injectable; Subcutaneous Lovenox (preservative Free) 30mg/0.3ml (100mg/ml) Injectable; Subcutaneous Lovenox (preservative Free) 40mg/0.4ml (100mg/ml) Injectable; Subcutaneous NewDrugInformation |